Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis

Bibliography

• MATZINGER P: Tolerance, danger, and the extended family. Annu. Rev. Immunol. (1994) 12:991-1045.
   Google Scholar
• CHRISTEN U, VON HERRATH MG: Initiation of autoimmunity. Curr. Opin. Immunol. (2004) 16:759-767.
   Web of Science ®Google Scholar
• ARIF S, TREE TI, ASTILL TP et al.: Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. (2004) 113:451-463.
   PubMed Web of Science ®Google Scholar
• VAN BILSEN JH, VAN DONGEN H, LARD LR et al.: Functional regulatory immune responses against human cartilage glycoprotein-39 in health versus proinflammatory responses in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA (2004) 101:17180-17185.
   PubMed Web of Science ®Google Scholar
• FEHERVARI Z, SAKAGUCHI S: CD4+ Tregs and immune control. J. Clin. Invest. (2004) 114:1209-1217.
   PubMed Web of Science ®Google Scholar
• MALOY KJ, POWRIE F: Regulatory T cells in the control of immune pathology. Nat. Immunol. (2001) 2:816-822.
   PubMed Web of Science ®Google Scholar
• BLUESTONE JA, ABBAS AK: Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. (2003) 3:253-257.
   PubMed Web of Science ®Google Scholar
• SAKAGUCHI S: Naturally arising Foxp3-expressing CD25(+)CD4(+) regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. (2005) 6:345-352.
   PubMed Web of Science ®Google Scholar
• RONCAROLO MG, BACCHETTA R, BORDIGNON C, NARULA S, LEVINGS MK: Type 1 T regulatory cells. Immunol. Rev. (2001) 182:68-79.
   Google Scholar
• O’GARRA A, STEINMAN L, GIJBELS K: CD4+ T-cell subsets in autoimmunity. Curr. Opin. Immunol. (1997) 9:872-883.
   Web of Science ®Google Scholar
• CHEN Y, KUCHROO VK, INOBE J, HAFLER DA, WEINER HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (1994) 265:1237-1240.
   PubMed Web of Science ®Google Scholar
• MOTTET C, UHLIG HH, POWRIE F: Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol. (2003) 170:3939-3943.
   PubMed Web of Science ®Google Scholar
• CHEN ML, PITTET MJ, GORELIK L et al.: Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc. Natl. Acad. Sci. USA (2005) 102:419-424.
   PubMed Web of Science ®Google Scholar
• LEE MK, MOORE DJ, JARRETT BP et al.: Promotion of allograft survival by CD4+CD25+ regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J. Immunol. (2004) 172:6539-6544.
   PubMed Web of Science ®Google Scholar
• JI J, MASTERSON J, SUN J, SOONG L: CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J. Immunol. (2005) 174:7147-7153.
   PubMed Web of Science ®Google Scholar
• TAYLOR MD, LEGOFF L, HARRIS A, MALONE E, ALLEN JE, MAIZELS RM: Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J. Immunol. (2005) 174:4924-4933.
   PubMed Web of Science ®Google Scholar
• SAKAGUCHI S, SAKAGUCHI N, ASANO M, ITOH M, TODA M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. (1995) 155:1151-1164.
   PubMed Web of Science ®Google Scholar
• ASANO M, TODA M, SAKAGUCHI N, SAKAGUCHI S: Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. (1996) 184:387-396.
   PubMed Web of Science ®Google Scholar
• BAECHER-ALLAN C, HAFLER DA: Suppressor T cells in human diseases. J. Exp. Med. (2004) 200:273-276.
   PubMed Web of Science ®Google Scholar
• DE KLEER IM, WEDDERBURN LR, TAAMS LS et al.: CD4+CD25(bright) regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. (2004) 172:6435-6443.
   PubMed Web of Science ®Google Scholar
• TAAMS L, VUKMANOVIC-STEJIC M, SALMON M, AKBAR A: Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance. Transplant. Immunol. (2003) 11:277-285.
   Google Scholar
• SOMERSET DA, ZHENG Y, KILBY MD, SANSOM DM, DRAYSON MT: Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology (2004) 112:38-43.
   PubMed Web of Science ®Google Scholar
• JONULEIT H, SCHMITT E, KAKIRMAN H, STASSEN M, KNOP J, ENK AH: Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J. Exp. Med. (2002) 196:255-260.
   PubMed Web of Science ®Google Scholar
• DIECKMANN D, BRUETT CH, PLOETTNER H, LUTZ MB, SCHULER G: Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J. Exp. Med. (2002) 196:247-253.
   PubMed Web of Science ®Google Scholar
• ANNUNZIATO F, COSMI L, LIOTTA F et al.: Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J. Exp. Med. (2002) 196:379-387.
   PubMed Web of Science ®Google Scholar
• LEVINGS MK, BACCHETTA R, SCHULZ U, RONCAROLO MG: The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int. Arch. Allergy Immunol. (2002) 129:263-276.
   PubMed Web of Science ®Google Scholar
• BAECHER-ALLAN C, BROWN JA, FREEMAN GJ, HAFLER DA: CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. (2001) 167:1245-1253.
   PubMed Web of Science ®Google Scholar
• BAECHER-ALLAN C, VIGLIETTA V, HAFLER DA: Human CD4+CD25+ regulatory T cells. Semin. Immunol. (2004) 16:89-98.
   Google Scholar
• ZHENG SG, WANG JH, GRAY JD, SOUCIER H, HORWITZ DA: Natural and induced CD4+CD25+ cells educate CD4+. J. Immunol. (2004) 172:5213-5221.
   PubMed Web of Science ®Google Scholar
• WALKER MR, KASPROWICZ DJ, GERSUK VH et al.: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+. J. Clin. Invest. (2003) 112:1437-1443.
   PubMed Web of Science ®Google Scholar
• DUTHOIT CT, NGUYEN P, GEIGER TL: Antigen nonspecific suppression of T cell responses by activated stimulation-refractory CD4+ T cells. J. Immunol. (2004) 172:2238-2246.
   PubMed Web of Science ®Google Scholar
• CHEN W, JIN W, HARDEGEN N et al.: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. (2003) 198:1875-1886.
   PubMed Web of Science ®Google Scholar
• FANTINI MC, BECKER C, MONTELEONE G, PALLONE F, GALLE PR, NEURATH MF: Cutting edge: TGF-beta induces a regulatory phenotype in CD4+. J. Immunol. (2004) 172:5149-5153.
   PubMed Web of Science ®Google Scholar
• MORGAN ME, VAN BILSEN JH, BAKKER AM et al.: Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum. Immunol. (2005) 66:13-20.
   Google Scholar
• VON HERRATH MG, HARRISON LC: Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. (2003) 3:223-232.
   PubMed Web of Science ®Google Scholar
• FUKAURA H, KENT SC, PIETRUSEWICZ MJ, KHOURY SJ, WEINER HL, HAFLER DA: Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. (1996) 98:70-77.
   PubMed Web of Science ®Google Scholar
• GROUX H, O’GARRA A, BIGLER M et al.: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 389:737-742.
   PubMed Web of Science ®Google Scholar
• MILLS KH, MCGUIRK P: Antigen-specific regulatory T cells-their induction and role in infection. Semin. Immunol. (2004) 16:107-117.
   Google Scholar
• MATTNER F, SMIROLDO S, GALBIATI F et al.: Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur. J. Immunol. (2000) 30:498-508.
   PubMed Web of Science ®Google Scholar
• LEVINGS MK, GREGORI S, TRESOLDI E, CAZZANIGA S, BONINI C, RONCAROLO MG: Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood (2005) 105:1162-1169.
   PubMed Web of Science ®Google Scholar
• RONCAROLO MG, GREGORI S, LEVINGS M: Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells. Novartis Found. Symp. (2003) 252:115-127.
   PubMedGoogle Scholar
• BARRAT FJ, CUA DJ, BOONSTRA A et al.: In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. (2002) 195:603-616.
   PubMed Web of Science ®Google Scholar
• WRAITH DC: Role of interleukin-10 in the induction and function of natural and antigen-induced regulatory T cells. J. Autoimmun. (2003) 20:273-275.
   PubMed Web of Science ®Google Scholar
• RONCAROLO MG, BATTAGLIA M, GREGORI S: The role of interleukin 10 in the control of autoimmunity. J. Autoimmun. (2003) 20:269-272.
   PubMed Web of Science ®Google Scholar
• MOORE KW, DE WAAL MR, COFFMAN RL, O’GARRA A: Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. (2001) 19:683-765.
   Google Scholar
• SUNDSTEDT A, O’NEILL EJ, NICOLSON KS, WRAITH DC: Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. (2003) 170:1240-1248.
   PubMed Web of Science ®Google Scholar
• BURKHART C, LIU GY, ANDERTON SM, METZLER B, WRAITH DC: Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int. Immunol. (1999) 11(10):1625-1634.
   PubMed Web of Science ®Google Scholar
• TANG Q, HENRIKSEN KJ, BI M et al.: In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. (2004) 199:1455-1465.
   PubMed Web of Science ®Google Scholar
• TARBELL KV, YAMAZAKI S, OLSON K, TOY P, STEINMAN RM: CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. (2004) 199:1467-1477.
   PubMed Web of Science ®Google Scholar
• HORWITZ DA, ZHENG SG, GRAY JD, WANG JH, OHTSUKA K, YAMAGIWA S: Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin. Immunol. (2004) 16:135-143.
   Google Scholar
• BLUESTONE JA: Regulatory T-cell therapy: is it ready for the clinic? Nat. Rev. Immunol. (2005) 5:343-349.
   PubMed Web of Science ®Google Scholar
• POCKLEY AG: Heat shock proteins as regulators of the immune response. Lancet (2003) 362:469-476.
   PubMed Web of Science ®Google Scholar
• LINDQUIST S, CRAIG EA: The heat shock proteins. Annu. Rev. Genet. (1988) 22:631-677.
   Google Scholar
• JINDAL S, DUDANI AK, SINGH B, HARLEY CB, GUPTA RS: Primary structure of a human mitochondrial protein homologous to the bacterial and plant chaperonins and to the 65-kilodalton mycobacterial antigen. Mol. Cell. Biol. (1989) 9:2279-2283.
   Web of Science ®Google Scholar
• KAUFFMANN SH: Heat shock proteins and the immune response. Immunol. Today (1990) 11:129-136.
   Web of Science ®Google Scholar
• KAUFMANN SH, VATH U, THOLE JE, VAN EMBDEN JD, EMMRICH F: Enumeration of T cells reactive with Mycobacterium tuberculosis organisms and specific for the recombinant mycobacterial 64-kDa protein. Eur. J. Immunol. (1987) 17:351-357.
   PubMed Web of Science ®Google Scholar
• SANCHEZ-CAMPILLO M, BINI L, COMANDUCCI M et al.: Identification of immunoreactive proteins of Chlamydia trachomatis by western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis (1999) 20:2269-2279.
   PubMed Web of Science ®Google Scholar
• MATTHEWS RC, MARESCA B, BURNIE JP et al.: Stress proteins in fungal diseases. Med. Mycol. (1998) 36(Suppl. 1):45-51.
   PubMed Web of Science ®Google Scholar
• OLDSTONE MB: Molecular mimicry and immune-mediated diseases. FASEB J. (1998) 12:1255-1265.
   PubMed Web of Science ®Google Scholar
• VAN EDEN W, VAN DER ZEE R, PRAKKEN B: Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat. Rev. Immunol. (2005) 5:318-330.
   PubMed Web of Science ®Google Scholar
• ANDERTON SM, VAN DER ZEE R, PRAKKEN B, NOORDZIJ A, VAN EDEN W: Activation of T-cells recognizing self 60 kDa heat shock protein can protect against experimental arthritis. J. Exp. Med. (1995) 181:943-952.
   PubMed Web of Science ®Google Scholar
• QUINTANA FJ, CARMI P, MOR F, COHEN IR: Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J. Immunol. (2002) 169(6):3422-3428.
   PubMed Web of Science ®Google Scholar
• PRAKKEN BJ, WENDLING U, VAN DER ZEE R, RUTTEN VP, KUIS W, VAN EDEN W: Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J. Immunol. (2001) 167(8):4147-4153.
   PubMed Web of Science ®Google Scholar
• VAN DE BROEK MF, HOGERVORST EJ, VAN BRUGGEN MC, VAN EDEN W, VAN DER ZEE R, VAN DEN BERG W: Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. J. Exp. Med. (1989) 170:449-466.
   PubMed Web of Science ®Google Scholar
• THOMPSON SJ, ROOK GA, BREALEY RJ, VAN DER ZEE R, ELSON CJ: Autoimmune reactions to heat-shock proteins in pristane-induced arthritis. Eur. J. Immunol. (1990) 20:2479-2484.
   PubMed Web of Science ®Google Scholar
• ELIAS D, ABLAMUNITS V, BIRK OS, CARMI P, KÖNEN-WAISMAN S, COHEN IR: Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various β-cell antigens. Diabetes (1997) 46:758-764.
   PubMed Web of Science ®Google Scholar
• BIRNBAUM G, KOTILINEK L, MILLER SD et al.: Heat shock proteins and experimental autoimmune encephalomyelitis. II: environmental infection and extra-neuraxial inflammation alter the course of chronic relapsing encephalomyelitis. J. Neuroimmunol. (1998) 90:149-161.
   PubMed Web of Science ®Google Scholar
• WENDLING U, PAUL L, VAN DER ZEE R, PRAKKEN B, SINGH M, VAN EDEN W: A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J. Immunol. (2000) 164:2711-2717.
   PubMed Web of Science ®Google Scholar
• DE GRAEFF-MEEDER ER, VAN DER ZEE R, RIJKERS GT et al.: Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet (1991) 337:1368-1372.
   PubMed Web of Science ®Google Scholar
• SPAHN TW, HEIMANN H, DUCHMANN R, VAN DER ZEE R, MEYER ZUM BUSCHENFELDE KH, LOHSE AW: Cellular and humoral immunity to the 60-kD heat shock protein in inflammatory bowel disease. Digestion (1997) 58:469-475.
   PubMed Web of Science ®Google Scholar
• RAMAGE JM, GASTON JS: Depressed proliferative responses by peripheral blood mononuclear cells from early arthritis patients to mycobacterial heat shock protein 60. Rheumatology (Oxford) (1999) 38:631-635.
   PubMed Web of Science ®Google Scholar
• ABULAFIA-LAPID R, ELIAS D, RAZ I, KEREN-ZUR Y, ATLAN H, COHEN IR: T cell proliferative responses of type 1 Diabetes patients and healthy individuals to human hsp60 and its peptides. J. Autoimmun. (1999) 12:121-129.
   PubMed Web of Science ®Google Scholar
• BASON C, CORROCHER R, LUNARDI C et al.: Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet (2003) 362:1971-1977.
   PubMed Web of Science ®Google Scholar
• CORRIGALL VM, BODMAN-SMITH MD, FIFE MS et al.: The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J. Immunol. (2001) 166:1492-1498.
   PubMed Web of Science ®Google Scholar
• WOO P: Cytokines and juvenile idiopathic arthritis. Curr. Rheumatol. Rep. (2002) 4:452-457.
   Web of Science ®Google Scholar
• PETTY RE, SOUTHWOOD TR, MANNERS P et al.: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J. Rheumatol. (2004) 31:390-392.
   PubMed Web of Science ®Google Scholar
• CRAWLEY E, KON S, WOO P: Hereditary predisposition to low interleukin-10 production in children with extended oligoarticular juvenile idiopathic arthritis. Rheumatology (Oxford) (2001) 40:574-578.
   PubMed Web of Science ®Google Scholar
• MURRAY KJ, GROM AA, THOMPSON SD, LIEUWEN D, PASSO MH, GLASS DN: Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J. Rheumatol. (1998) 25:1388-1398.
   PubMed Web of Science ®Google Scholar
• THOMPSON SD, LUYRINK LK, GRAHAM TB et al.: Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J. Immunol. (2001) 166:6899-6906.
   PubMed Web of Science ®Google Scholar
• IELLEM A, MARIANI M, LANG R et al.: Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J. Exp. Med. (2001) 194:847-853.
   PubMed Web of Science ®Google Scholar
• RUPRECHT CR, GATTORNO M, FERLITO F et al.: Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J. Exp. Med. (2005) 201:1793-1803.
   PubMed Web of Science ®Google Scholar
• LIFE P, HASSEL A, WILLIAMS K et al.: Responses to Gram-negative enteric bacterial antigens by synovial T cells from patients with juvenile chronic arthritis: recognition of heat shock protein hsp60. J. Rheumatol. (1993) 20:1388-1396.
   PubMed Web of Science ®Google Scholar
• ALBANI S, RAVELLI A, MASSA M et al.: Immune responses to the Escherichia coli dnaJ heat shock protein in juvenile rheumatoid arthritis and their correlation with disease activity. J. Pediatr. (1994) 124:561-565.
   PubMed Web of Science ®Google Scholar
• DE GRAEFF-MEEDER ER, VAN EDEN W, RIJKERS GT et al.: Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favourable course of arthritis. J. Clin. Invest. (1995) 95:934-940.
   PubMed Web of Science ®Google Scholar
• PRAKKEN AB, VAN EDEN W, RIJKERS GT et al.: Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum. (1996) 39:1826-1832.
   PubMed Web of Science ®Google Scholar
• DE KLEER IM, KAMPHUIS SM, RIJKERS GT et al.: The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum. (2003) 48:2001-2010.
   PubMed Web of Science ®Google Scholar
• SOUTHWOOD S, SIDNEY J, KONDO A et al.: Several common HLA-DR types share largely overlapping peptide binding repertoires. J. Immunol. (1998) 160:3363-3373.
   PubMed Web of Science ®Google Scholar
• SETTE A: Tools of the trade in vaccine design. Science (2000) 290:2074-2075.
   PubMedGoogle Scholar
• KAMPHUIS S, KUIS W, DE JAGER W et al.: Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet (2005) 366:50-56.
   PubMed Web of Science ®Google Scholar
• BITAR DM, WHITACRE CC: Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. (1988) 112:364-370.
   Web of Science ®Google Scholar
• ANDERTON SM, WRAITH DC: Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur. J. Immunol. (1998) 28:1251-1261.
   PubMed Web of Science ®Google Scholar
• LIU JQ, BAI XF, SHI FD et al.: Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99. Int. Immunol. (1998) 10:1139-1148.
   PubMed Web of Science ®Google Scholar
• STAINES NA, HARPER N, WARD FJ, MALMSTRÖM V, HOLMDAHL R, BANSAL S: Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin. Exp. Immunol. (1996) 103:368-375.
   Google Scholar
• PRAKKEN BJ, VAN DER ZEE R, ANDERTON SM, VAN KOOTEN PJ, KUIS W, VAN EDEN W: Peptide induced nasal tolerance for a mycobacterial hsp60 T cell epitope in rats suppresses both adjuvant arthritis and non-microbially induced experimental arthritis. Proc. Natl. Acad. Sci. USA (1997) 94:3284-3289.
   PubMed Web of Science ®Google Scholar
• TIAN Y, ATKINSON MA, CLARE-SALZLER M et al.: Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. (1996) 183:1561-1567.
   PubMed Web of Science ®Google Scholar
• DANIEL D, WEGMANN DR: Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23). Proc. Natl. Acad. Sci. USA (1996) 93:956-960.
   PubMed Web of Science ®Google Scholar
• AL-SABBAGH A, NELSON PA, AKSELBAND Y, SOBEL RA, WEINER HL: Antigen-driven peripheral immune tolerance:suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen. Cell. Immunol. (1996) 171:111-119.
   Web of Science ®Google Scholar
• NAGLER-ANDERSON C, BOBER LA, ROBINSON ME, SISKIND GW, THORBECKE GJ: Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc. Natl. Acad. Sci. USA (1986) 83:7443-7446.
   PubMed Web of Science ®Google Scholar
• CHEN W, JIN W, COOK M, WEINER HL, WAHL SM: Oral delivery of group A streptococcal cell walls augments circulating TGF-beta and suppresses streptococcal cell wall arthritis. J. Immunol. (1998) 161:6297-6304.
   PubMed Web of Science ®Google Scholar
• MA SW, ZHAO DL, YIN ZQ et al.: Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat. Med. (1997) 3:793-796.
   PubMed Web of Science ®Google Scholar
• MA S, HUANG Y, YIN Z, MENASSA R, BRANDLE JE, JEVNIKAR AM: Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4. Proc. Natl. Acad. Sci. USA (2004) 101:5680-5685.
   PubMed Web of Science ®Google Scholar
• STEINMAN L: Immune therapy for autoimmune diseases. Science (2004) 305:212-216.
   PubMed Web of Science ®Google Scholar
• TANAKA S, KIMURA Y, MITANI A et al.: Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis. J. Immunol. (1999) 163:5560-5565.
   PubMed Web of Science ®Google Scholar
• DURAI M, GUPTA RS, MOUDGIL KD: The T cells specific for the carboxyl-terminal determinants of self (rat) heat-shock protein 65 escape tolerance induction and are involved in regulation of autoimmune arthritis. J. Immunol. (2004) 172:2795-2802.
   PubMed Web of Science ®Google Scholar
• WEINER HL: Current issues in the treatment of human diseases by mucosal tolerance. Ann. NY Acad. Sci. (2004) 1029:211-224.
   PubMed Web of Science ®Google Scholar
• TRENTHAM DE, DYNESIUS-TRENTHAM RA, ORAV JE et al.: Effects of oral administration of type II collagen on rheumatoid arthritis. Science (1993) 261:1727-1730.
   PubMed Web of Science ®Google Scholar
• WEINER HL, MACKIN GA, MATSUI M et al.: Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science (1993) 259:1321-1324.
   PubMed Web of Science ®Google Scholar
• MCKOWN KM, CARBONE LD, KAPLAN SB et al.: Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis. Arthritis Rheum. (1999) 42:1204-1208.
   PubMed Web of Science ®Google Scholar
• POZZILLI P, PITOCCO D, VISALLI N et al.: No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group. Diabetologia (2000) 43:1000-1004.
   PubMed Web of Science ®Google Scholar
• RAZ I, ELIAS D, AVRON A, TAMIR M, METZGER M, COHEN IR: Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, Phase II trial. Lancet (2001) 358:1749-1753.
   PubMed Web of Science ®Google Scholar
• KAPPOS L, COMI G, PANITCH H et al.: Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized Phase II trial. Nat. Med. (2000) 6:1176-1182.
   PubMed Web of Science ®Google Scholar
• BIELEKOVA B, GOODWIN B, RICHERT N et al.: Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a Phase II clinical trial with an altered peptide ligand. Nat. Med. (2000) 6:1167-1175.
   PubMed Web of Science ®Google Scholar
• PRAKKEN BJ, SAMODAL R, LE TD et al.: Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA (2004) 101:4228-4233.
   PubMed Web of Science ®Google Scholar
• VANDERLUGT C, MILLER SD: Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. (2002) 2:85-95.
   PubMed Web of Science ®Google Scholar